Sign Up
OverviewAPI
Sensorion, a biotechnology company specializing in gene therapies for inner ear disorders, is holding a Combined Shareholders' General Meeting on December 20, 2023, in Paris, France. The meeting will address agenda items and draft resolutions published in the BALO on November 15, 2023. Sensorion's clinical-stage portfolio includes gene therapy programs and small molecule programs for hearing loss disorders.

Ask a question